How to buy TRACON Pharmaceuticals stock (TCON)

TRACON Pharmaceuticals is a biotechnology business based in the US. TRACON Pharmaceuticals shares (TCON) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.03 – the same closing value as a week prior. TRACON Pharmaceuticals employs 17 staff and has a trailing 12-month revenue of around $3.2 million.

Our top picks for where to buy TRACON Pharmaceuticals stock

Buy TRACON Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

TRACON Pharmaceuticals stock price (OTCQB: TCON)

Use our graph to track the performance of TCON stocks over time.

TRACON Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.03
52-week range	$0.02 - $14.75
50-day moving average more info button	$0.05
200-day moving average more info button	$1.28
Wall St. target price	$6.00
PE ratio more info button	0.0054
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$5.93

Is it a good time to buy TRACON Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TRACON Pharmaceuticals price performance over time

Historical closes compared with the close of $0.0322 from 2024-12-02

1 week (2024-12-10)	N/A
1 month (2024-11-21)	9.15%
3 months (2024-09-20)	-81.60%
6 months (2024-06-21)	-97.42%

1 year (2023-12-21)	-81.28%
2 years (2022-12-21)	-99.88%
3 years (2021-12-21)	58.4
5 years (2019-12-20)	48.8

Is TRACON Pharmaceuticals stock undervalued or overvalued?

Valuing TRACON Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TRACON Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

TRACON Pharmaceuticals's P/E ratio

TRACON Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, TRACON Pharmaceuticals shares trade at around 0x recent earnings.

TRACON Pharmaceuticals financials

Revenue TTM	$3.2 million
Gross profit TTM	$-13,888,000
Return on assets TTM	-59.37%
Return on equity TTM	-1277.01%
Profit margin	162.34%
Book value	$-0.91
Market Capitalization more info button	$109,725

TTM: trailing 12 months

TRACON Pharmaceuticals share dividends

We're not expecting TRACON Pharmaceuticals to pay a dividend over the next 12 months.

Have TRACON Pharmaceuticals's shares ever split?

TRACON Pharmaceuticals's shares were split on a 1:20 basis on 9 April 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TRACON Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for TRACON Pharmaceuticals shares which in turn could have impacted TRACON Pharmaceuticals's share price.

TRACON Pharmaceuticals share price volatility

Over the last 12 months, TRACON Pharmaceuticals's shares have ranged in value from as little as $0.021 up to $14.746. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while TRACON Pharmaceuticals's is 1.422. This would suggest that TRACON Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

TRACON Pharmaceuticals overview

TRACON Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic T-lymphocyte-associated protein 4 IgG1 monoclonal antibody that is in Phase I clinical trial for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. In addition, it is developing bispecific antibodies, which are in preclinical stage. It has collaboration and license agreements with 3D Medicines Co. , Ltd.

Frequently asked questions

What percentage of TRACON Pharmaceuticals is owned by insiders or institutions?
Currently 1.732% of TRACON Pharmaceuticals shares are held by insiders and 4.036% by institutions. How many people work for TRACON Pharmaceuticals?
Latest data suggests 17 work at TRACON Pharmaceuticals. When does the fiscal year end for TRACON Pharmaceuticals?
TRACON Pharmaceuticals's fiscal year ends in December. Where is TRACON Pharmaceuticals based?
TRACON Pharmaceuticals's address is: 4350 La Jolla Village Drive, San Diego, CA, United States, 92122 What is TRACON Pharmaceuticals's ISIN number?
TRACON Pharmaceuticals's international securities identification number is: US89237H2094 What is TRACON Pharmaceuticals's CUSIP number?
TRACON Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 89237H209